ConductScience.org, home

Trial · NCT01436500

Participant flow15

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTED5 mg Ifetroban12
Overall StudySTARTED15 mg Ifetroban12
Overall StudySTARTED50 mg Ifetroban12
Overall StudySTARTED150 mg Ifetroban6
Overall StudySTARTEDPlacebo13
Overall StudyCOMPLETED5 mg Ifetroban9
Overall StudyCOMPLETED15 mg Ifetroban9
Overall StudyCOMPLETED50 mg Ifetroban7
Overall StudyCOMPLETED150 mg Ifetroban5
Overall StudyCOMPLETEDPlacebo9
Overall StudyNOT COMPLETED5 mg Ifetroban3
Overall StudyNOT COMPLETED15 mg Ifetroban3
Overall StudyNOT COMPLETED50 mg Ifetroban5
Overall StudyNOT COMPLETED150 mg Ifetroban1
Overall StudyNOT COMPLETEDPlacebo4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01436500/flow